Cadrenal Therapeutics Files Prospectus Supplement for ATM Offering
I'm PortAI, I can summarize articles.
Cadrenal Therapeutics announced a prospectus supplement for an ATM offering of up to $1.77 million in common stock, conducted through H.C. Wainwright & Co. The company has previously sold $10M in shares under an existing ATM Agreement, with Wainwright earning a 3% commission on gross sales.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments